Items where Author is "Hanley, NA"
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.
Article
Athwal, VS and Pritchett, James and Llewellyn, J and Martin, K and Camacho, E and Raza, SMA and Phythian‐Adams, A and Birchall, LJ and Mullan, AF and Su, K and Pearmain, L and Dolman, G and Zaitoun, AM and Friedman, SL and MacDonald, A and Irving, WL and Guha, IN and Hanley, NA and Piper Hanley, K
(2017)
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.
EMBO Molecular Medicine, 9 (12).
pp. 1696-1710.
ISSN 1757-4676
Martin, K and Pritchett, J and Llewellyn, J and Mullan, AF and Athwal, VS and Dobie, R and Harvey, E and Zeef, L and Farrow, S and Streuli, C and Henderson, NC and Friedman, SL and Hanley, NA and Piper Hanley, K
(2016)
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.
Nature Communications, 7.
ISSN 2041-1723
Pritchett, J and Athwal, VS and Harvey, E and Martin, K and Llewellyn, J and Ireland, P and Nicolaides, A and Humphries, MJ and Bobola, N and Hanley, NA and Piper Hanley, K
(2014)
Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells.
PloS one, 9 (6).
ISSN 1932-6203
Pritchett, J and Harvey, E and Athwal, V and Berry, A and Rowe, C and Oakley, F and Moles, A and Mann, DA and Bobola, N and Sharrocks, AD and Thomson, BJ and Zaitoun, AM and Irving, WL and Guha, IN and Hanley, NA and Hanley, KP
(2012)
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.
Hepatology, 56 (3).
pp. 1108-1116.
ISSN 0270-9139